A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease.
- DOI
- 10.1183/13993003.02567-2025
- Published
- 2026 Aug 6
- Container
- The European respiratory journal
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1183/13993003.02567-2025,
title = {A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease.},
author = {Saralaya D and Mustapa MN and Ferreira J and Kocks JWH and Brailsford W and Rosengren S and Spata E and Belvisi MG and Leander J and Riff C and De Palo G and Windgassen D and Chalmers JD and Russell REK and Hurst JR and Śmiałowski A and Hughes R},
year = {2026},
journal = {The European respiratory journal},
doi = {10.1183/13993003.02567-2025},
url = {https://doi.org/10.1183/13993003.02567-2025}
}RIS
TY - JOUR TI - A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease. AU - Saralaya D AU - Mustapa MN AU - Ferreira J AU - Kocks JWH AU - Brailsford W AU - Rosengren S AU - Spata E AU - Belvisi MG AU - Leander J AU - Riff C AU - De Palo G AU - Windgassen D AU - Chalmers JD AU - Russell REK AU - Hurst JR AU - Śmiałowski A AU - Hughes R PY - 2026 JO - The European respiratory journal DO - 10.1183/13993003.02567-2025 UR - https://doi.org/10.1183/13993003.02567-2025 ER -
APA
D, S., MN, M., J, F., JWH, K., W, B., S, R., E, S., MG, B., J, L., C, R., G, D. P., D, W., JD, C., REK, R., JR, H., A, Ś., & R, H. (2026). A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease.. The European respiratory journal. https://doi.org/10.1183/13993003.02567-2025
Source records
- pubmed · retrieved 2026-09-25T06:19:12.768Z
- europe-pmc · retrieved 2026-09-25T06:19:12.770Z